SB1306 exempts chemical mixtures containing gamma-butyrolactone from California's controlled substances regulations when used in semiconductor.
SB1306 amends the Health and Safety Code to exempt chemical mixtures containing gamma-butyrolactone (GBL) from California's controlled substances regulations when used in semiconductor manufacturing. This change aligns California law with federal exemptions, which consider GBL mixtures with a concentration of 70 percent or less to pose minimal risk of diversion for illicit purposes. The bill aims to reduce regulatory burdens on semiconductor manufacturers, ensuring California remains competitive in the semiconductor industry.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.